Tango Therapeutics Inc (NASDAQ: TNGX) started the day on Wednesday, with a price decrease of -5.57% at $6.27, before settling in for the price of $6.64 at the close. Taking a more long-term approach, TNGX posted a 52-week range of $6.33-$13.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 132.62% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is -22.90%. This publicly-traded company’s shares outstanding now amounts to $102.20 million, simultaneously with a float of $57.71 million. The organization now has a market capitalization sitting at $671.77 million. At the time of writing, stock’s 50-day Moving Average stood at $8.80, while the 200-day Moving Average is $9.11.
Tango Therapeutics Inc (TNGX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Tango Therapeutics Inc’s current insider ownership accounts for 46.14%, in contrast to 56.76% institutional ownership. According to the most recent insider trade that took place on Oct 21 ’24, this organization’s sold 625,000 shares at the rate of 7.05, making the entire transaction reach 4,406,250 in total value, affecting insider ownership by 7,573,642. Preceding that transaction, on Oct 22 ’24, Company’s sold 250,000 for 6.78, making the whole transaction’s value amount to 1,695,000. This particular insider is now the holder of 7,323,642 in total.
Tango Therapeutics Inc (TNGX) Earnings and Revenue Records
Tango Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -22.90% and is forecasted to reach -1.46 in the upcoming year.
Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators
Let’s observe the current performance indicators for Tango Therapeutics Inc (TNGX). It’s Quick Ratio in the last reported quarter now stands at 7.49. The Stock has managed to achieve an average true range (ATR) of 0.55. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 15.80.
In the same vein, TNGX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.13, a figure that is expected to reach -0.37 in the next quarter, and analysts are predicting that it will be -1.46 at the market close of one year from today.
Technical Analysis of Tango Therapeutics Inc (TNGX)
If we take a close look at the recent performances of Tango Therapeutics Inc (NASDAQ: TNGX), its last 5-days Average volume was 1.35 million that shows progress from its year to date volume of 0.76 million. During the previous 9 days, stock’s Stochastic %D was recorded 36.92% While, its Average True Range was 0.52.
Raw Stochastic average of Tango Therapeutics Inc (TNGX) in the period of the previous 100 days is set at 2.54%, which indicates a major fall in contrast to 11.16% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 59.04% that was lower than 76.40% volatility it exhibited in the past 100-days period.
